Kim Mi Ran, Kim Hyun Jin, Yu Su Hyun, Lee Bo Su, Jeon Se Yeong, Lee Jeong Jun, Lee Young Chul
Natural Product Team, Naturech Co, Ltd., Chungcheongnam-do 31257, Republic of Korea.
Evid Based Complement Alternat Med. 2020 May 23;2020:7941391. doi: 10.1155/2020/7941391. eCollection 2020.
Red clover and hops are already known for their alternative menopausal therapies; however, their combination has not yet been studied. This study aimed to evaluate the efficacy of the combination of red clover and hops extract (RHEC) for treating menopausal symptoms for the first time. A high-performance liquid chromatography (HPLC) method for RHEC was developed and validated for the analysis of biochanin A in red clover extract and xanthohumol in hops extract. An in vivo study was conducted using an ovariectomized rat model treated with RHEC (125, 250, and 500 mg/kg, p.o.) for a 12-week test period. Changes in body weight, tail skin temperature (TST), serum lipid profile, bone metabolism, antioxidants, and markers of vasorelaxation and uterus endometrium were evaluated. RHEC significantly inhibited body weight gain and decreased fat weight. Changes in TST associated with flashes were significantly inhibited in the RHEC groups. Other markers related to menopausal symptoms, such as blood lipid profile (total cholesterol and low-density-lipoprotein cholesterol), bone metabolism (serum alkaline phosphatase, osteocalcin, and c-terminal telopeptide type 1), antioxidants (superoxide dismutase and malondialdehyde), and vasorelaxants (endothelin-1 and nitric oxide), were significantly improved after the administration of RHEC. We also confirmed the safety of RHEC through histopathological observation of the endometrium. Our findings demonstrate that RHEC appears to have high potential for comprehensively improving various symptoms of menopause.
红三叶草和啤酒花已因替代更年期疗法而闻名;然而,它们的组合尚未得到研究。本研究旨在首次评估红三叶草和啤酒花提取物组合(RHEC)治疗更年期症状的疗效。开发并验证了一种用于RHEC的高效液相色谱(HPLC)方法,用于分析红三叶草提取物中的生物chanin A和啤酒花提取物中的黄腐酚。使用经卵巢切除的大鼠模型进行体内研究,用RHEC(125、250和500mg/kg,口服)治疗12周的试验期。评估体重、尾皮温度(TST)、血清脂质谱、骨代谢、抗氧化剂以及血管舒张和子宫内膜标志物的变化。RHEC显著抑制体重增加并降低脂肪重量。RHEC组中与潮热相关的TST变化得到显著抑制。其他与更年期症状相关的标志物,如血脂谱(总胆固醇和低密度脂蛋白胆固醇)、骨代谢(血清碱性磷酸酶、骨钙素和I型c端肽)、抗氧化剂(超氧化物歧化酶和丙二醛)以及血管舒张剂(内皮素-1和一氧化氮),在给予RHEC后均有显著改善。我们还通过子宫内膜的组织病理学观察证实了RHEC的安全性。我们的研究结果表明,RHEC似乎具有全面改善更年期各种症状的巨大潜力。